Mignemi G, Garozzo A, Livatino A, Di Leo L
I Clinica Ostetrica e Ginecologica, Università degli Studi di Catania.
Minerva Ginecol. 1994 Apr;46(4):167-72.
During 1992 and 1993, twenty-eight women with uterine leiomyomata received GnRH-agonist (leuprolide acetate) for 3 months before hysterectomy or myomectomy. The decrease in uterine volume and secondary anemia with its collateral effects were assessed, then surgical and post-surgical advantages were assessed too. The real advantages of this treatment are studied and distinguished from theoretic advantages.
1992年至1993年期间，28名患有子宫平滑肌瘤的女性在子宫切除术或肌瘤切除术前行3个月的促性腺激素释放激素激动剂（醋酸亮丙瑞林）治疗。评估子宫体积减小情况及继发性贫血及其附带影响，同时也评估手术及术后优势。对该治疗的实际优势进行研究，并与理论优势相区分。
